Developer docs
API playgroundTry for free, no card

Search company profiles

kitozyme

Full company profile

uuid000fevi

Namestring
kitozyme
Legal namestring
KitoZyme S.A.
Websiteurl
kitozyme.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

KitoZyme S.A. is a Belgian biopolymer manufacturer founded in December 2000 and headquartered in Herstal, Belgium, with 11-50 employees. The company specializes in extracting and commercializing fungal chitosan and chitin-glucan from Aspergillus niger mycelium, a co-product stream from industrial citric acid production. Its proprietary process yields pharmaceutical-grade, vegan, non-GMO, halal, kosher, and gluten-free biopolymers with antimicrobial, chelation, film-forming, and prebiotic properties, manufactured under ISO 13485 quality systems.

The company operates a B2B ingredients model, supplying these biopolymers to brand owners and formulators across four verticals: consumer healthcare (weight management via KiOslim and digestive health), cosmetics (KiOsmetine), agriculture (KitoGreen for biocontrol and biostimulants), and oenology (KiOfine). Products are marketed through vertical-specific sub-brands, including KiOnutrime for nutritional applications and KiOtransine for delivery systems. Revenue is generated through ingredient sales, private-label finished products (KiOslim, Gastrap Direct), and technology licensing/royalty arrangements, with distribution executed via channel partners spanning approximately 30 countries across Europe, North America, South America, Oceania, and Africa. Two wholly-owned subsidiaries, KiOmed Pharma (joint-health medical devices, spun off 2014) and BiOkuris (intestinal-disease medical nutrition, spun off 2021), extend the chitosan platform into adjacent regulated verticals.

Short descriptiontext

KitoZyme is a Belgian manufacturer of pharmaceutical-grade fungal chitosan and chitin-glucan ingredients extracted from Aspergillus niger, supplying B2B customers across consumer healthcare, cosmetics, agriculture, and winemaking in approximately 30 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHerstal, Belgium
HQ citystring
Herstal
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fungal chitosan manufacturing, chitin-glucan biopolymers, agricultural biopesticide ingredients, weight management chitosan, winemaking oenological chitosan
Industry1 code
PRIMARYCRADAOAD
Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin)
NAICS code1 code
  • Plastics Materials and Basic Forms and Shapes Merchant Wholesalers42461
SIC code1 code
  • Food And Kindred Products2000
Product category
Specialty Biopolymer Ingredients
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Ingredient Sales
TypeOne Time License
Description

B2B sales of fungal chitosan and chitin-glucan ingredients to manufacturers in healthcare, cosmetics, agriculture, and food & beverage industries. Products sold under proprietary brand names (KiOsmetine, KiOnutrime, KiOfine, KitoGreen) or as private label formulations.

kitozyme.com
2Finished Consumer Products
TypeOne Time License
Description

Sales of branded finished products including KiOslim weight management supplement, Gastrap Direct medical device for digestive health, available under own brands or private label arrangements.

kitozyme.com
3Technology Licensing
TypeLicensing Royalties
Description

Exclusive licensing arrangements for specific applications such as the Janssen PMP partnership for post-harvest preservation technology and DPH Biologicals for U.S. agricultural applications.

kitozyme.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1KiOsmetine
Description

Patented range of non-animal chitosan for cosmetics and personal care, including hair care, skin care, color cosmetics, deodorant, and oral care. Includes KiOsmetine CsG for Hair Care, KiOsmetine P for Oral Care, and KiOsmetine Lumina for Skin care & Styling.

kitozyme.com
+6 more records
Core offering1 text field

KitoZyme manufactures and markets fungal-origin chitosan and chitin-glucan biopolymers extracted from Aspergillus niger mycelium, selling these as ingredients under industry-specific sub-brands to enterprise manufacturers in consumer healthcare, cosmetics & personal care, agriculture, and winemaking. The company also markets finished consumer health products (KiOslim® weight management supplement, Gastrap® Direct medical device) under its own brand and via private label arrangements, reaching approximately 30 countries with 500K+ finished products sold annually and 200M+ bottles treated annually in winemaking applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Chitosan supplementation resulted in 3.10 kg mean weight loss over 90 days in clinical trial
+5 more records
Product overview1 text field

KitoZyme is a manufacturer and supplier of fungal-origin biopolymers, operating as a B2B ingredients company. The portfolio centers on two core ingredients—Fungal Chitosan and Fungal Chitin-Glucan—extracted from Aspergillus niger. These ingredients are marketed across multiple industry-specific sub-brands: KiOsmetine® (cosmetics/personal care), KiOnutrime® CsG and KiOslim® (weight management), KitoGreen® product line (agriculture), KiOfine® (winemaking), KiOtransine® and Gastrap® Direct (digestive health). The company also operates subsidiaries KiOmed Pharma (joint health) and BiOkuris (chronic intestinal diseases). Products are sold as ingredients for B2B formulation or as finished consumer health products.

Product and service13 records
1Fungal Chitosan
CategoryCore biopolymer ingredient
Description

Patented vegetal chitosan biopolymer extracted from Aspergillus niger fungal source (non-animal, non-GMO) with antimicrobial, immune activation, anti-inflammatory, and chelation properties. Sold as a B2B ingredient to manufacturers in healthcare, cosmetics, agriculture, and winemaking. FDA-GRAS certified and manufactured under ISO 13485.

2Fungal Chitin-Glucan
CategoryCore biopolymer ingredient
Description

Complex tridimensional biopolymer combining chitin and beta (1,3) glucan extracted from fungal cell walls. Classified as FDA-GRAS and EU Novel Food. Sold to manufacturers for prebiotic applications and digestive health products.

3KiOsmetine®
CategoryCosmetics & personal care ingredients
Description

Patented range of non-animal chitosan ingredients for cosmetics and personal care. Includes KiOsmetine CsG for hair care, KiOsmetine P for oral care, and KiOsmetine Lumina for skin care and styling. Eco-certified by ECOCERT GREENLIFE and COSMOS compliant. Targets cosmetics brand owners and personal care manufacturers needing vegan, non-allergenic film-forming and antimicrobial ingredients.

4KiOnutrime® CsG
CategoryWeight management ingredients
Description

Clinically proven vegan chitosan fat binder ingredient for weight management. Binds dietary fats efficiently, reduces caloric absorption, and contributes to cholesterol control. GRAS certified in USA. Sold as a B2B ingredient to nutraceutical and supplement manufacturers.

5KiOslim®
CategoryFinished consumer health product
Description

Natural fat binder food supplement for weight management, sold as a finished B2C product. Reduces appetite, prevents excessive eating and cravings, binds dietary fat, and reduces carbohydrate absorption. 88% user satisfaction rate and 40% better results than diet alone in user studies.

6KitoGreen®
CategoryAgricultural biopesticide
Description

World's first vegetal chitosan for agriculture. EPA-approved biopesticide and EU-approved Basic Substance for plant protection. Activates natural plant defense mechanisms against fungal threats (Botrytis, mildew), promotes plant health and stress tolerance, and reduces the need for chemical pesticides. Approved for organic agriculture across all 27 EU countries.

7KitoGreen Master
CategoryAgricultural biopesticide
Description

EPA-approved fungicide based on patented fungal chitosan. Offers fungicidal applications, biostimulant properties, and adjuvant uses for sustainable agriculture.

8KitoGreen Prevent
CategoryAgricultural biopesticide
Description

Biocontrol product for crop protection based on fungal chitosan technology, used preventatively to activate plant defense mechanisms.

9KitoGreen Extend
CategoryAgricultural biopesticide
Description

Product based on fungal chitosan technology designed to extend the shelf life of crops, supporting sustainable agriculture and post-harvest preservation.

10ChitoNox FC
CategoryAgricultural seed treatment
Description

Sustainably-sourced chitosan seed treatment technology developed with DPH Biologicals. Provides biological crop protection against nematodes and soil-borne diseases. First EPA-registered sustainably-sourced chitosan seed treatment for U.S. growers.

11KiOfine®
CategoryWinemaking ingredients
Description

Range of non-animal fungal chitosan and chitin-glucan ingredients for winemaking. Authorized by the OIV (International Organization of Vine and Wines). Provides tools for microbiological control (Brettanomyces), sulfite reduction, anti-oxidation, clarification, fining, and heavy metal chelation. Distributed via Lallemand Group and ICV partnerships.

12KiOtransine®
CategoryDigestive health ingredients
Description

Prebiotic fiber derived from chitin-glucan that restores intestinal microbiota, supports digestive health, and improves transit. Produces short-chain fatty acids including butyrate and propionate. Sold as a B2B ingredient to nutraceutical and supplement manufacturers.

13Gastrap® Direct
CategoryFinished medical device product
Description

Medical device Class IIa combining chitin-glucan with simethicone. Used for relief of gas-related symptoms, regularization of intestinal transit, and normalization of intestinal function. 67% of IBS patients reported significant abdominal pain reduction and 93% rated tolerability as good or very good in clinical studies.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-26
Description

Strategic partnership to develop and commercialize ChitoNox FC, the first sustainably-sourced chitosan seed treatment technology for U.S. growers. The product offers biological crop protection against nematodes and soil-borne diseases, based on KitoZyme's EPA-registered KitoGreen technology. Commercially available for 2025 crop season.

2Phyteurop
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-29
Description

Commercial partnership making Phyteurop the distributor in France for KitoZyme's fungal chitosan for foliar applications. Phyteurop, a major plant protection products player in France with cooperative ownership model, will distribute PLEIONE brand product starting 2024, primarily for vineyard applications against downy mildew and powdery mildew.

kitozyme.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-05-08
Description

Exclusive Collaboration Agreement to evaluate and develop KitoZyme technologies for post-harvest use on fresh produce globally. KitoZyme granted Janssen PMP exclusive right to evaluate chitosan technologies for post-harvest storage preservation of fruits and vegetables. Leverages Janssen PMP's 50+ years of experience in post-harvest treatments.

4Lallemand Group
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Global cooperation for winemaking applications. Products delivered under Lallemand's trademarks for distribution to winemakers globally.

kitozyme.com
5ICV (Institut Coopératif du Vin)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Cooperation with ICV for winemaking applications in France. ICV distributes KiOfine B brand in South of France for Brettanomyces population control.

kitozyme.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
1Qingdao Yunzhou Biochemistry Co., Ltd.
TypeDirect peer
Description

Chinese manufacturer of chitosan and chitin derivatives for industrial and food applications. Comparable as a large-scale chitosan producer competing in the same global market, typically at lower price points.

TypeBroad incumbent
Description

Dutch sustainable ingredients company with operations in food preservation, anti-microbials, and algae-based biopolymers. Comparable as a fermentation-derived biopolymer producer with overlap in food protection and sustainable ingredient markets.

TypeDirect peer
Description

German manufacturer of chitosan for medical, pharmaceutical, and cosmetic applications. Directly comparable as a specialty chitosan producer serving overlapping B2B customer segments.

4Lallemand Inc.
TypeDirect peer
Description

Canadian yeast and bacteria specialist with significant oenology business. Functions as both a channel partner and a peer, supplying microbiological control and processing aids to the same winemaking customers KitoZyme serves with KiOfine.

TypeDirect peer
Description

Iceland-based chitosan manufacturer producing from shrimp shell sources for nutraceutical, cosmetic, and food applications. Comparable as an established chitosan producer identified as a key player in the same market research as KitoZyme.

6Golden-Shell Pharmaceutical Co., Ltd.
TypeDirect peer
Description

Chinese chitosan and chitin-glucan manufacturer serving nutraceutical, food, and cosmetic customers. Identified alongside KitoZyme as a key player in the global chitosan market, with significant scale advantage.

TypeDirect peer
Description

U.S. biological crop protection company and KitoZyme's partner on ChitoNox FC seed treatment. Comparable as a peer operating in the same agricultural biocontrol/biostimulant market, with potential overlap as products expand.

TypeEmerging player
Description

Sweden-based chitosan specialist focused on industrial and life-science applications. Comparable as an emerging specialty chitosan producer serving research and industrial customers, with smaller scale than KitoZyme.

TypeBroad incumbent
Description

Global specialty ingredients company supplying personal care, health, and crop protection markets. Comparable as a broad incumbent that supplies comparable ingredient categories (cosmetics actives, agricultural biosolutions) with much greater scale.

TypeBroad incumbent
Description

Italian producer of bio-based and biodegradable materials from renewable sources. Comparable as a biopolymer manufacturer with broader product portfolio and well-established position in sustainable materials, partly overlapping with KitoZyme's biopolymer platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

kitozyme

Specialty Biopolymer Ingredientskitozyme.com

KitoZyme is a Belgian manufacturer of pharmaceutical-grade fungal chitosan and chitin-glucan ingredients extracted from Aspergillus niger, supplying B2B customers across consumer healthcare, cosmetics, agriculture, and winemaking in approximately 30 countries.

What kitozyme does

KitoZyme S.A. is a Belgian biopolymer manufacturer founded in December 2000 and headquartered in Herstal, Belgium, with 11-50 employees. The company specializes in extracting and commercializing fungal chitosan and chitin-glucan from Aspergillus niger mycelium, a co-product stream from industrial citric acid production. Its proprietary process yields pharmaceutical-grade, vegan, non-GMO, halal, kosher, and gluten-free biopolymers with antimicrobial, chelation, film-forming, and prebiotic properties, manufactured under ISO 13485 quality systems.

The company operates a B2B ingredients model, supplying these biopolymers to brand owners and formulators across four verticals: consumer healthcare (weight management via KiOslim and digestive health), cosmetics (KiOsmetine), agriculture (KitoGreen for biocontrol and biostimulants), and oenology (KiOfine). Products are marketed through vertical-specific sub-brands, including KiOnutrime for nutritional applications and KiOtransine for delivery systems. Revenue is generated through ingredient sales, private-label finished products (KiOslim, Gastrap Direct), and technology licensing/royalty arrangements, with distribution executed via channel partners spanning approximately 30 countries across Europe, North America, South America, Oceania, and Africa. Two wholly-owned subsidiaries, KiOmed Pharma (joint-health medical devices, spun off 2014) and BiOkuris (intestinal-disease medical nutrition, spun off 2021), extend the chitosan platform into adjacent regulated verticals.

kitozyme firmographics

Firmographics
Name
kitozyme
Legal name
KitoZyme S.A.
Website
https://kitozyme.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
KitoZyme is a Belgian manufacturer of pharmaceutical-grade fungal chitosan and chitin-glucan ingredients extracted from Aspergillus niger, supplying B2B customers across consumer healthcare, cosmetics, agriculture, and winemaking in approximately 30 countries.
Ownership category
akta.pro rank

kitozyme industry classification

Industry
Product category
Specialty Biopolymer Ingredients
NAICS
Plastics Materials and Basic Forms and Shapes Merchant Wholesalers (42461)
SIC
Food And Kindred Products (2000)
akta.pro industry
PRIMARYCRADAOAD
Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin)

Keywords

  • Fungal chitosan manufacturing
  • Chitin-glucan biopolymers
  • Agricultural biopesticide ingredients
  • Weight management chitosan
  • Winemaking oenological chitosan

Where kitozyme is headquartered

Location

Headquarters

HQ city
Herstal
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

kitozyme business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Ingredient Sales: B2B sales of fungal chitosan and chitin-glucan ingredients to manufacturers in healthcare, cosmetics, agriculture, and food & beverage industries. Products sold under proprietary brand names (KiOsmetine, KiOnutrime, KiOfine, KitoGreen) or as private label formulations.
  2. Finished Consumer Products: Sales of branded finished products including KiOslim weight management supplement, Gastrap Direct medical device for digestive health, available under own brands or private label arrangements.
  3. Technology Licensing: Exclusive licensing arrangements for specific applications such as the Janssen PMP partnership for post-harvest preservation technology and DPH Biologicals for U.S. agricultural applications.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

kitozyme product offering

Product offering

Core offering

KitoZyme manufactures and markets fungal-origin chitosan and chitin-glucan biopolymers extracted from Aspergillus niger mycelium, selling these as ingredients under industry-specific sub-brands to enterprise manufacturers in consumer healthcare, cosmetics & personal care, agriculture, and winemaking. The company also markets finished consumer health products (KiOslim® weight management supplement, Gastrap® Direct medical device) under its own brand and via private label arrangements, reaching approximately 30 countries with 500K+ finished products sold annually and 200M+ bottles treated annually in winemaking applications.

Product overview

KitoZyme is a manufacturer and supplier of fungal-origin biopolymers, operating as a B2B ingredients company. The portfolio centers on two core ingredients—Fungal Chitosan and Fungal Chitin-Glucan—extracted from Aspergillus niger. These ingredients are marketed across multiple industry-specific sub-brands: KiOsmetine® (cosmetics/personal care), KiOnutrime® CsG and KiOslim® (weight management), KitoGreen® product line (agriculture), KiOfine® (winemaking), KiOtransine® and Gastrap® Direct (digestive health). The company also operates subsidiaries KiOmed Pharma (joint health) and BiOkuris (chronic intestinal diseases). Products are sold as ingredients for B2B formulation or as finished consumer health products.

Differentiator

Problem solved

Functional benefit

Brands

  • KiOsmetine: Patented range of non-animal chitosan for cosmetics and personal care, including hair care, skin care, color cosmetics, deodorant, and oral care. Includes KiOsmetine CsG for Hair Care, KiOsmetine P for Oral Care, and KiOsmetine Lumina for Skin care & Styling.
  • KiOnutrime
  • KiOslim
  • KiOfine
  • KiOtransine
  • Gastrap Direct
  • KitoGreen

Products and services

  • Fungal Chitosan Patented vegetal chitosan biopolymer extracted from Aspergillus niger fungal source (non-animal, non-GMO) with antimicrobial, immune activation, anti-inflammatory, and chelation properties. Sold as a B2B ingredient to manufacturers in healthcare, cosmetics, agriculture, and winemaking. FDA-GRAS certified and manufactured under ISO 13485.
  • Fungal Chitin-Glucan Complex tridimensional biopolymer combining chitin and beta (1,3) glucan extracted from fungal cell walls. Classified as FDA-GRAS and EU Novel Food. Sold to manufacturers for prebiotic applications and digestive health products.
  • KiOsmetine® Patented range of non-animal chitosan ingredients for cosmetics and personal care. Includes KiOsmetine CsG for hair care, KiOsmetine P for oral care, and KiOsmetine Lumina for skin care and styling. Eco-certified by ECOCERT GREENLIFE and COSMOS compliant. Targets cosmetics brand owners and personal care manufacturers needing vegan, non-allergenic film-forming and antimicrobial ingredients.
  • KiOnutrime® CsG Clinically proven vegan chitosan fat binder ingredient for weight management. Binds dietary fats efficiently, reduces caloric absorption, and contributes to cholesterol control. GRAS certified in USA. Sold as a B2B ingredient to nutraceutical and supplement manufacturers.
  • KiOslim® Natural fat binder food supplement for weight management, sold as a finished B2C product. Reduces appetite, prevents excessive eating and cravings, binds dietary fat, and reduces carbohydrate absorption. 88% user satisfaction rate and 40% better results than diet alone in user studies.
  • KitoGreen® World's first vegetal chitosan for agriculture. EPA-approved biopesticide and EU-approved Basic Substance for plant protection. Activates natural plant defense mechanisms against fungal threats (Botrytis, mildew), promotes plant health and stress tolerance, and reduces the need for chemical pesticides. Approved for organic agriculture across all 27 EU countries.
  • KitoGreen Master EPA-approved fungicide based on patented fungal chitosan. Offers fungicidal applications, biostimulant properties, and adjuvant uses for sustainable agriculture.
  • KitoGreen Prevent Biocontrol product for crop protection based on fungal chitosan technology, used preventatively to activate plant defense mechanisms.
  • KitoGreen Extend Product based on fungal chitosan technology designed to extend the shelf life of crops, supporting sustainable agriculture and post-harvest preservation.
  • ChitoNox FC Sustainably-sourced chitosan seed treatment technology developed with DPH Biologicals. Provides biological crop protection against nematodes and soil-borne diseases. First EPA-registered sustainably-sourced chitosan seed treatment for U.S. growers.
  • KiOfine® Range of non-animal fungal chitosan and chitin-glucan ingredients for winemaking. Authorized by the OIV (International Organization of Vine and Wines). Provides tools for microbiological control (Brettanomyces), sulfite reduction, anti-oxidation, clarification, fining, and heavy metal chelation. Distributed via Lallemand Group and ICV partnerships.
  • KiOtransine® Prebiotic fiber derived from chitin-glucan that restores intestinal microbiota, supports digestive health, and improves transit. Produces short-chain fatty acids including butyrate and propionate. Sold as a B2B ingredient to nutraceutical and supplement manufacturers.
  • Gastrap® Direct Medical device Class IIa combining chitin-glucan with simethicone. Used for relief of gas-related symptoms, regularization of intestinal transit, and normalization of intestinal function. 67% of IBS patients reported significant abdominal pain reduction and 93% rated tolerability as good or very good in clinical studies.

Quantifiable outcome

  • Chitosan supplementation resulted in 3.10 kg mean weight loss over 90 days in clinical trial
  • +5 more outcomes

Companies that use kitozyme

Customer profile

Segments4 records

Ideal customer profiles5 records

kitozyme technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

kitozyme partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • DPH BiologicalscoreStrategic or Co-development Partner · 26 June 2024Strategic partnership to develop and commercialize ChitoNox FC, the first sustainably-sourced chitosan seed treatment technology for U.S. growers. The product offers biological crop protection against nematodes and soil-borne diseases, based on KitoZyme's EPA-registered KitoGreen technology. Commercially available for 2025 crop season.
  • PhyteuropcoreChannel Partner/ Reseller/ Distributor · 29 November 2023Commercial partnership making Phyteurop the distributor in France for KitoZyme's fungal chitosan for foliar applications. Phyteurop, a major plant protection products player in France with cooperative ownership model, will distribute PLEIONE brand product starting 2024, primarily for vineyard applications against downy mildew and powdery mildew.
  • Janssen PMP (Janssen Pharmaceutica NV / Johnson & Johnson)coreStrategic or Co-development Partner · 8 May 2023Exclusive Collaboration Agreement to evaluate and develop KitoZyme technologies for post-harvest use on fresh produce globally. KitoZyme granted Janssen PMP exclusive right to evaluate chitosan technologies for post-harvest storage preservation of fruits and vegetables. Leverages Janssen PMP's 50+ years of experience in post-harvest treatments.
  • Lallemand GroupminorChannel Partner/ Reseller/ DistributorGlobal cooperation for winemaking applications. Products delivered under Lallemand's trademarks for distribution to winemakers globally.
  • ICV (Institut Coopératif du Vin)minorChannel Partner/ Reseller/ DistributorCooperation with ICV for winemaking applications in France. ICV distributes KiOfine B brand in South of France for Brettanomyces population control.

Scale indicators5 records

Recent moves8 records

Expansion highlights7 records

kitozyme competitors and assessment

Company assessment

Direct peers

  • Qingdao Yunzhou Biochemistry Co., Ltd. Chinese manufacturer of chitosan and chitin derivatives for industrial and food applications. Comparable as a large-scale chitosan producer competing in the same global market, typically at lower price points.
  • Heppe Medical Chitosan GmbH: German manufacturer of chitosan for medical, pharmaceutical, and cosmetic applications. Directly comparable as a specialty chitosan producer serving overlapping B2B customer segments.
  • Lallemand Inc. Canadian yeast and bacteria specialist with significant oenology business. Functions as both a channel partner and a peer, supplying microbiological control and processing aids to the same winemaking customers KitoZyme serves with KiOfine.
  • Primex EHF: Iceland-based chitosan manufacturer producing from shrimp shell sources for nutraceutical, cosmetic, and food applications. Comparable as an established chitosan producer identified as a key player in the same market research as KitoZyme.
  • Golden-Shell Pharmaceutical Co., Ltd. Chinese chitosan and chitin-glucan manufacturer serving nutraceutical, food, and cosmetic customers. Identified alongside KitoZyme as a key player in the global chitosan market, with significant scale advantage.
  • DPH Biologicals: U.S. biological crop protection company and KitoZyme's partner on ChitoNox FC seed treatment. Comparable as a peer operating in the same agricultural biocontrol/biostimulant market, with potential overlap as products expand.

Broad incumbents

  • Corbion NV: Dutch sustainable ingredients company with operations in food preservation, anti-microbials, and algae-based biopolymers. Comparable as a fermentation-derived biopolymer producer with overlap in food protection and sustainable ingredient markets.
  • Croda International plc: Global specialty ingredients company supplying personal care, health, and crop protection markets. Comparable as a broad incumbent that supplies comparable ingredient categories (cosmetics actives, agricultural biosolutions) with much greater scale.
  • Novamont S.p.A. Italian producer of bio-based and biodegradable materials from renewable sources. Comparable as a biopolymer manufacturer with broader product portfolio and well-established position in sustainable materials, partly overlapping with KitoZyme's biopolymer platform.

Emerging players

  • ChitoLytic AB: Sweden-based chitosan specialist focused on industrial and life-science applications. Comparable as an emerging specialty chitosan producer serving research and industrial customers, with smaller scale than KitoZyme.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

kitozyme social profiles

Digital presence

kitozyme compliance and trust

Trust signal

Compliance7 records

kitozyme financial estimates

Financial estimate

Revenue estimate

Valuation estimate

kitozyme leadership team

Management profile

Number of profiles

Profiles6 records

kitozyme subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

kitozyme funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

kitozyme M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about kitozyme

What does kitozyme do?

KitoZyme manufactures and markets fungal-origin chitosan and chitin-glucan biopolymers extracted from Aspergillus niger mycelium, selling these as ingredients under industry-specific sub-brands to enterprise manufacturers in consumer healthcare, cosmetics & personal care, agriculture, and winemaking. The company also markets finished consumer health products (KiOslim® weight management supplement, Gastrap® Direct medical device) under its own brand and via private label arrangements, reaching approximately 30 countries with 500K+ finished products sold annually and 200M+ bottles treated annually in winemaking applications.

Is kitozyme a public or private company?

kitozyme is a private company. It is classified as venture growth investor backed and is currently operating.

When was kitozyme founded?

kitozyme was founded in 2000. It employs 11 to 50 people.

Where is kitozyme based?

kitozyme is headquartered in Herstal, Belgium, in the Europe region.

How does kitozyme make money?

Three revenue lines are on record. Ingredient Sales are the primary driver. The others are finished Consumer Products and technology Licensing.

Who are kitozyme's main competitors?

Direct peers on record are Qingdao Yunzhou Biochemistry Co., Ltd., Heppe Medical Chitosan GmbH, Lallemand Inc., Primex EHF, Golden-Shell Pharmaceutical Co., Ltd. and DPH Biologicals. Broad incumbents are Corbion NV, Croda International plc and Novamont S.p.A.. ChitoLytic AB is listed as an emerging player.

Does kitozyme have an API?

No public API is recorded for kitozyme.

What industry is kitozyme in?

kitozyme's product category is Specialty Biopolymer Ingredients. Its primary akta.pro industry code is CRADAOAD, Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin). Its NAICS code is 42461 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal Chitosan Market | 14.3% CAGR Growth Trajectory | Pharmaceutical, Cosmetic & Nutraceutical Demand Drive Expansion | KitoZyme, Primex, Heppe Medical Lead High-Purity Biopolymer InnovationFuture Market Insights released a market analysis projecting the global chitosan market to grow from USD 2.00 billion in 2025 to USD 7.61 billion by 2036, representing a 14.3% CAGR driven by accelerating demand in pharmaceutical, biomedical, cosmetic, and dietary supplement applications. The report identifies the United States (14.2% CAGR) and Japan (13.9% CAGR) as the fastest-growing markets, while noting that approximately 90% of commercial chitin is sourced from shrimp and crab shell waste, tying pricing dynamics to seafood processing volumes. Key companies in the competitive landscape include KitoZyme S.A., Heppe Medical Chitosan GmbH, Primex EHF, Golden-Shell Pharmaceutical Co., Ltd., and Qingdao Yunzhou Biochemistry Co., Ltd., with medical-grade chitosan commanding prices 10 to 20 times higher than food-grade variants.Cosmetics BusinessClariant and KitoZyme enter partnershipClariant and KitoZyme announced a long-term partnership to launch a range of biopolymers for personal care, available from October 2011 under Clariant's trade names. The products are extracted from vegetal sources and are eco-friendly and cost-effective. The partnership aims to expand Clariant's product portfolio with differentiated technology ingredients.Market Research FutureChitin, Chitosan and Derivatives Market Demand, Size, Share, GrowthMarket Research Future projects the Chitin, Chitosan, and Derivatives Market to grow from $5.192 billion in 2025 to $17.41 billion by 2035, driven by sustainability trends and technological advancements in extraction. Key industry players including KitoZyme, FMC Corporation, and Primex are expanding operations and R&D to capitalize on rising demand in pharmaceuticals, agriculture, and biodegradable packaging sectors.PR NewswireGlobal Chitin & Chitosan Derivatives Market Report 2018: Analysis & Forecasts (2016-2024) - Potential Applications in Medicine to Drive GrowthResearchAndMarkets.com released a strategic business report covering the global chitin and chitosan derivatives market, with annual estimates and forecasts for the period 2016 through 2024. The report analyzes market data segmented by derivatives (glucosamine, chitosan, others) and end-use applications including water treatment, cosmetics, food and beverages, healthcare/medical, and agrochemicals. Key recent industry activity highlighted includes FMC selling its health and nutrition business to DuPont, Dober's acquisition of the Haloklear product line from HaloSource, and various product launches by companies including Medtronic and KitoZyme.